176 related articles for article (PubMed ID: 7332636)
1. Uptake and metabolism of catecholamines in rat brain synaptosomes: studies on the contribution of monoamine oxidase.
Urwyler S; von Wartburg JP
Biochem Pharmacol; 1981 Oct; 30(20):2777-85. PubMed ID: 7332636
[No Abstract] [Full Text] [Related]
2. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
Neff NH; Costa E
J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
[No Abstract] [Full Text] [Related]
3. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
Nguyen TB; Angers M
Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
[TBL] [Abstract][Full Text] [Related]
4. Monoamine oxidase-catalyzed metabolism of 3,4-dihydroxyphenylethylamine in the dopaminergic synaptosomes from rat corpus striatum.
Katz IR
J Neurochem; 1982 Mar; 38(3):859-62. PubMed ID: 7057199
[TBL] [Abstract][Full Text] [Related]
5. Influence of harmaline on the ability of pargyline to alter catecholamine metabolism in rats.
Fuller RW; Hemrick-Luecke SK; Perry KW
Biochem Pharmacol; 1981 Jun; 30(11):1295-8. PubMed ID: 7271828
[No Abstract] [Full Text] [Related]
6. Influence of vesicular storage and monoamine oxidase activity on [11C]phenylephrine kinetics: studies in isolated rat heart.
Raffel DM; Wieland DM
J Nucl Med; 1999 Feb; 40(2):323-30. PubMed ID: 10025842
[TBL] [Abstract][Full Text] [Related]
7. Catecholamine degradation by monoamine oxidase in locus coeruleus neurons of the rat. An immunohistochemical study.
Kishimoto Y; Geffard M; Arai R
Brain Res; 2000 Mar; 859(2):373-7. PubMed ID: 10719089
[TBL] [Abstract][Full Text] [Related]
8. Influence of intraneuronal inactivating mechanisms on the membrane-amine pump.
Graefe KH; Trendelenburg U
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):336-7. PubMed ID: 4253778
[No Abstract] [Full Text] [Related]
9. Neurocatin-induced inhibition of monoamine oxidase A in rat brain synaptosomes.
Fernandez-Novoa L; Pastuszko A; Wilson DF
Biochem Pharmacol; 1991 Nov; 42(12):2351-4. PubMed ID: 1764118
[TBL] [Abstract][Full Text] [Related]
10. Kinetic studies on rat brain monoamine oxidase.
Huszti Z
Mol Pharmacol; 1972 Jul; 8(4):385-97. PubMed ID: 5053580
[No Abstract] [Full Text] [Related]
11. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
Vetulani J; Reichenberg K
Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
[No Abstract] [Full Text] [Related]
12. Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
Javoy F; Youdim MB; Agid Y; Glowinski J
J Neural Transm; 1973; 34(4):279-89. PubMed ID: 4149516
[No Abstract] [Full Text] [Related]
13. Carrier-mediated efflux of [3H]dopamine and [3H]1-methyl-4-phenylpyridine: effect of ascorbic acid.
Debler EA; Sershen H; Hashim A; Lajtha A; Reith ME
Synapse; 1991 Feb; 7(2):99-105. PubMed ID: 2011830
[TBL] [Abstract][Full Text] [Related]
14. Effect of reserpine and other drugs on the monoamine metabolism with special reference to the CNS.
Andén NE
Ann Med Exp Biol Fenn; 1968; 46(3):361-6. PubMed ID: 4308996
[No Abstract] [Full Text] [Related]
15. Regional differences in the high affinity uptake or 3H-dopamine and 3H-norepinephrine in synaptosome rich homogenates of cat brain.
Garey RE
Life Sci; 1976 Feb; 18(4):411-8. PubMed ID: 1256245
[No Abstract] [Full Text] [Related]
16. [Effect of MAO inhibitors on impeding synaptosomal withdrawal and on dopamine metabolism in rat and human brain].
Tóthfalusi L; Tekes K; Gaál J; Magyar K
Acta Pharm Hung; 1989; 59 Suppl 1():75-9. PubMed ID: 2641638
[No Abstract] [Full Text] [Related]
17. Effects of DL-2-amino-5-phosphonovalerate on metabolism of catecholamines in synaptosomes from rat brain.
Yee DK; Pastuszko A; Nelson D; Wilson DF
J Neurochem; 1989 Jan; 52(1):54-60. PubMed ID: 2562811
[TBL] [Abstract][Full Text] [Related]
18. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
Gong SN; Rogers KJ
Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
[TBL] [Abstract][Full Text] [Related]
19. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
Green AR; Mitchell BD; Tordoff AF; Youdim MB
Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
[No Abstract] [Full Text] [Related]
20. The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain.
Neff NH; Yang HY; Fuentes JA
Adv Biochem Psychopharmacol; 1974; 12(0):49-57. PubMed ID: 4609330
[No Abstract] [Full Text] [Related]
[Next] [New Search]
